Related Experiment Video

Updated: Mar 19, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.4K

Letter: Beyond Association-Operationalising PRS-5 for Hepatocellular Carcinoma Surveillance

Jiajing Zhao1, Liping Liu1,2

  • 1Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, the Second Clinical Medical College, Jinan University, Shenzhen, China.

Alimentary Pharmacology & Therapeutics
|March 18, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
antiviral agentsgenetic risk scorehepatitis Chepatocellular carcinoma

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining07:43

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Published on: May 9, 2025

817

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248